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Introduction
The recent developments in cardiovascular imaging have led to a number of options for the in non-invasive investigation of heart disease. Echocardiography, due to its widespread availability and relative cost, will remain the initial investigation of choice.
Computed tomography coronary angiography (CTCA) and single-photon emission computed tomography (SPECT) are widely adopted internationally for the investigation of stable coronary disease, and positron emission tomography (PET) and hybrid technologies appear to have future potential.
Cardiovascular magnetic resonance (CMR) is an established advanced crosssectional imaging modality for the functional and anatomical assessment of a wide range of cardiovascular disease. CMR is safe, does not use ionising radiation, provides diagnostic and prognostic information, and guides patient management. [1, 2] The relative duration of the scan time, expense and lack of portability, however, puts the onus on CMR to demonstrate superiority over other imaging modalities. The extensive and growing evidence base for CMR has established it as the reference standard imaging test for many cardiovascular conditions. As such CMR is firmly established in both national and international clinical guidelines [3] [4] [5] [6] with recognised international training syllabi and accreditation/certification processes. [7] [8] [9] CMR demand continues to expand, particularly in the UK, where there was a reported 253% increase in scans performed between 2008 and 2013. [10] There is also high demand in some European countries [1] , which is being driven predominantly by increased referral rates for imaging of known/suspected coronary artery disease (CAD), cardiomyopathy and adult congenital heart disease (ACHD). A British Cardiovascular Society working group predicted that by 2015 there would be a need for ~2275 scans per million of population, which for the current UK population of over 60 million would equate to a trebling of demand in the 5 years from 2010-2015.
One of the key advantages of CMR is its multi-parametric approach, due to the availability of numerous different pulse sequences which can be applied to interrogate different aspects of the cardiovascular system and diagnose its pathological processes. Not all techniques can/are performed in all patients, therefore to select/request a comprehensive imaging protocol, the user should understand the full range of MR pulse sequences and their clinical applications. In this review we will outline the basic CMR physics and the pulse sequences, describe the established clinical indications and the application of CMR for these, and finally describe the emerging techniques and future developments.
A) Basic CMR Physics, Methodology & Safety
Basic CMR Physics
CMR imaging uses a strong superconducting magnet (cooled in liquid helium) to produce images with high spatial resolution, excellent soft tissue contrast and ability to define any tomographic plane. [11] The magnet operates at a field strength measured in units of Tesla (T), with 1T ≈ 20,000 times the earth's magnetic field. Three types of magnetic fields are used to produce images: a strong, static magnetic field (B0), magnetic field gradients (which can be rapidly switched on and off and are used to encode spatial information) and a radiofrequency (RF) field.
CMR uses the signal generated from magnetising hydrogen nuclei (protons) which are naturally abundant in biological tissues. When a patient is placed into the scanner the protons within free water and lipid molecules align their magnetic 'moment' (direction)
either parallel or anti-parallel to the static B0 field. Slightly more nuclei align in the parallel direction, so together they produce a net magnetisation in the longitudinal direction. For imaging purposes an RF pulse is applied, delivering energy to the protons, which tilt the magnetisation away from alignment with B0 and into the transverse plane. When this extrinsic RF pulse is removed, magnetisation returns gradually to its equilibrium state, releasing this energy in the form of a radiofrequency signal. This process is repeated several times with different magnetic gradients applied to generate the image data.
The relaxation of protons back to their equilibrium state after withdrawal of the RF pulse is defined by two important parameters known as T1 and T2. [12] The T1 relaxation time is defined as the duration taken for approximately 63% of the recovery of longitudinal magnetisation to occur. This increases with increasing magnetic field strength. T2 relaxation is the time when 63% of the transverse magnetisation of excited tissues has decayed and exhibits substantially less dependence on magnetic field strength. In biological tissues, T2 values are substantially shorter than T1. Fat has short T1 and T2 relaxation; fluids have long T1 and T2 relaxation; and non-fatty soft tissues (e.g. myocardium) have long T1 and short T2 relaxation.
Both the delay between successive RF pulses (Repetition Time, TR) and between each RF application and subsequent signal readout (Echo Time, TE) can be specified by the operator. [12] This is exploited for purposes of tissue characterisation by permitting imaging sequences preferentially weighted to T1 (T1w:short TE and TR,) or T2 (T2w:long TE and TR). Image contrast can also be adjusted by the introduction of additional magnetisation preparation steps, such as saturation or inversion RF pulses.
The two most commonly used pulse sequence types in CMR are Spin Echo (SE) and Gradient Recalled Echo (GRE). SE sequences are generally used for static anatomical definition. SE produces high quality T1w and T2w images and is termed black-blood imaging (as blood appears black). [13] On T1w SE images, fluid typically appears dark and fat bright, whereas both are bright on T2w images.
GRE sequences permit fast cine acquisition (motion) with high temporal resolution and typically generate bright-blood images (both blood and fat are bright). [14] In addition to standard cine imaging, it is also possible to assess intra-myocardial motion by "tagging" the myocardium with a grid pattern and then tracking its deformation through the cardiac cycle. [15] Analysis of the displacement of tagging features permits measurement of myocardial strain, strain rate and torsion. [16] Furthermore the measurement of strain with feature tracking software using standard cine images is widely available. [17] Flowing blood can be given a different phase value compared to stationary tissue when certain magnetic fields are applied. These are used in phase-contrast GRE sequences, also called velocity encoded sequences, which are used to quantify blood flow velocity. A velocity image is by generated, known as a phase-map, in which pixel intensity depends upon the phase of the transverse magnetisation, rather than its magnitude. [18] Pixels are displayed as either dark (moving away from the phaseencoding direction), bright (towards) or mid-grey (stationary). Phase-contrast velocity mapping is typically used to measure blood flow e.g. aortic or pulmonary valvular regurgitation [19] and total flow volumes per cardiac cycle with both forward and reverse flow components measurable(Fig6e). CMR allows precise alignment of the imaging plane (in-plane or through-plane) with the direction of flow but is limited by temporal resolution (typically 25-45ms, 10-fold lower than Doppler echocardiography) and thus may underestimate peak values in high velocity jets (e.g. severe aortic stenosis). [20] The duration of a CMR scan typically ranges from 30 minutes to an hour depending on the complexity of the referral question(s). Patients are breath-held for the acquisition of most images, which with modern fast scanners can be just a few seconds in duration, and this can be adjusted according to patient ability. Vectorcardiogram (equivalent to ECG) triggering and gating are used to prevent image distortion due to cardiac motion; [21] with cine images acquired during the entire cardiac cycle (prospective triggering or retrospective gating [22] ) and static images preferentially acquired during diastole (prospective triggering). Most images are acquired over a number of cardiac cycles (segmented imaging) such that arrhythmias and poor breath holding can degrade image quality, [23] although in most cases diagnostic quality information can still be obtained by using arrhythmia rejection algorithms, non-breath holding (free breathing) or single-shot acquisition.
Image Quality and Artefacts
CMR image acquisition can be associated with a number of classical artefacts, [24] although in the vast majority of cases an experienced technologist can minimise these to produce diagnostic quality images. The most common include:
-Image aliasing: indicative of too small a field a view with signal from peripheral parts of the body wrapping centrally into the main image.
-Ghosting artefact from respiratory motion: caused by movement of tissue between each TR with subsequent misplacement of signal in the image.
-Arrhythmia artefact: Cardiac arrhythmia, or poor quality ECG triggering, generates cardiac motion artefacts during cine acquisition due variation in R-R intervals.
-Chemical shift artefact: typically a signal void at the interface between fat layers and surrounding water-based tissue. It is important to recognise in order to avoid misinterpretation e.g. the false impression of aortic wall dissection "flap".
-Metallic artefact: can significantly degrade images, appearing as a large signal void and surrounding geometric distortion; particularly affecting GRE based pulse sequences.
-Dark-rim artefact: refers to a band of transient low signal in the endocardium during first-pass perfusion imaging when contrast agent first enters the LV cavity. Unlike genuine regions of hypoperfusion the low signal resolves within a few heartbeats as myocardial enhancement occurs. Further reading on this subject can be found in this 2-part review. [12, 18] 
CMR Safety and the Safety of Implanted Medical Devices
The magnetic field of the MR scanner is ALWAYS on and although the magnetic field is strongest within the bore of the magnet, the surrounding fringe field can also adversely affect pacemakers and other implants. Importantly, any ferromagnetic objects will accelerate towards the magnet bore, posing a projectile hazard with potentially fatal consequences (e.g. oxygen cylinder, wheelchairs etc). For these reasons, health and safety regulations dictate a controlled area must be defined enclosing the 0.5mT fringe field. [25] 
CMR Contrast Agents: Indications and Safety
Intravenously administered gadolinium chelate-based contrast agents (GBCA)(0.1-0.2mmol/Kg), are typically extracellular (distributing in both the intravascular and interstitial compartments) and highly paramagnetic, [28] shortening T1 relaxation times and increasing signal intensity on T1w images.
The reported incidence of allergic reactions to gadolinium is very low (~1:10,000); at least one order of magnitude lower than that of iodinated contrast agents. [29] The use of several GBCA in patients with advanced renal insufficiency has been associated with Nephrogenic Systemic Fibrosis, [30] although newer 'cyclic' contrast agents appear not to cause this condition. The FDA advises avoiding GBCA in patients with acute or chronic severe renal insufficiency (eGFR<30ml/min/1.73m 2 ), renal dysfunction of any severity due to the hepato-renal syndrome or in the perioperative liver transplant period (unless diagnostic information is essential and otherwise unattainable). Those patients with severe renal insufficiency receiving GBCA should be considered for haemodialysis to enhance the contrast agent's elimination. Although no harm has been reported during pregnancy, GBCA's cross the placental barrier and are not recommended in pregnant patients unless the benefits outweigh the risks. [25] Breastfeeding can continue uninterrupted after the use of GBCA.
[31]
B. Established Clinical Indications for CMR
The most common referral indications for CMR are for the assessment of myocardial ischaemia & viability, heart failure, cardiomyopathy and ACHD. CMR offers a unique multi-parametric assessment, detailing anatomy, function and flow, delineating scar from healthy myocardium, providing accurate tissue characterisation and with the addition of stress techniques, can identify inducible myocardial ischaemia. [32] CMR is the reference standard for assessment of left and right ventricular (RV) volumes and function.
Stable Coronary Artery Disease
CMR is established for the investigation of patients presenting with stable chest pain.
The 2013 European Society of Cardiology (ESC) guidelines on the management of stable CAD [4] give a Class I recommendation (Level of evidence B) for non-invasive stress testing for those patients with a pre-test probability of 15-85%, with stress perfusion CMR being one of the recommended imaging options.
A CMR study for this purpose typically includes cine imaging in multiple planes for from normal myocardium appears dark (black). In acute MI the volume of distribution of the contrast agent is increased due to the destruction of sarcolemmal membranes and wash-out is delayed, thus more contrast is retained at the time of imaging, shortening the T1 of the tissue. Imaging is performed so that infarcted myocardium appears bright (white). Similarly, in chronic MI, the presence of replacement fibrotic tissue increases the contrast volume of distribution, such that chronic MI's also appear bright (white). This process of tissue characterisation is unique to CMR and is now one of the most fundamental techniques in CMR practice (see later in this review).
-Coronary Artery Imaging Unlike cardiac CT coronary angiography which produces exquisite anatomical images of the coronary arteries, the clinical utility of detection coronary artery stenosis by magnetic resonance angiography (MRA) remains to be established. This is due to the required long imaging times, more limited spatial resolution, and the impact of cardiac and respiratory motion on MRA image quality. The CE-MARC study demonstrated that the inclusion of MRA had no additional overall diagnostic benefit within the multiparametric protocol of myocardial perfusion, left ventricular function and viability assessment [33, 40] , which has been supported by other CMR data [41] . Coronary MRA, however, is useful for detecting the location of coronary aneurysms (such as those seen in Kawasaki disease), and the presence of anomalous coronary arteries with accurate delineation of their anatomical course [42] ; the principal advantage of MRA being the lack of ionising radiation in children and younger adults.
-Cost Effectiveness of CMR
The use of CMR as the initial strategy for the detection of coronary artery disease has been shown to be cost effective using both the United Kingdom's National Institute for
Health and Care Excellence guidance for lower and upper limit thresholds (£20-30,000) per quality adjusted life year (QALY) [43] and in other international healthcare models. [44, 45] -Future Clinical Direction
Technological advances in acquisition techniques (software) and hardware (scanners with higher field strengths and improved cardiac phased-array coils) have allowed the development of advanced perfusion techniques. These use highly accelerated pulse sequences based on spatio-temporal undersampling which allow the acquisition of high resolution images (in-plane<1.5mm 2 ) [46] permitting the detection of subendocardial myocardial ischaemia and 3D whole heart myocardial perfusion imaging with full left ventricular coverage. [47, 48] Other techniques such as blood oxygen level dependent (BOLD) imaging [49] and arterial spin labelling (ASL) [50] are able to detect myocardial ischaemia without the use of contrast agents. BOLD uses the inherent magnetic differences between oxygenated and deoxygenated blood to detect differences in signal intensity in ischaemic vs. non-ischaemic myocardium, and is able to detect 'ischaemic' myocardium through the use of vasodilator stress techniques'. [49] . In terms of future CMR provision and clinical service planning, the National Horizon Scanning Centre suggested that CMR may become the gold standard for assessing myocardial viability [51] and the preferred option for myocardial perfusion imaging. [52] 2) Acute Myocardial Infarction
Multi-parametric imaging with CMR has high diagnostic accuracy for the detection of CAD in the assessment of both ST-segment and non-ST-segment elevation acute coronary syndromes [53, 54] , and also has the ability to give insight into the pathological consequences of acute myocardial infarction (AMI).
-Myocardial Oedema.
Myocardial oedema occurs when prolonged ischaemia triggers an inflammatory response in reversibly injured myocytes and is a very early marker of acute myocardial injury, developing before both ischaemic myocardial necrosis or even troponin release. [55] T2w imaging is a non-contrast scan which exploits the different paramagnetic properties of water-bound protons with long T2 relaxation times to provide intrinsic (water-specific) image contrast(Fig2a). These images however typically have low signal-to-noise ratio (SNR) and require experience to interpret. This technique is able to differentiate acute from chronic infarction [56, 57] . T2w imaging also allows accurate delineation of the area-at-risk (AAR) in acute infarction [56] and can be used to estimate myocardial salvage index (MSI), which is calculated by subtracting the infarcted area (determined by LGE imaging) from the oedematous area likely to exhibit functional recovery, whilst those segments with >75% transmurality are unlikely to benefit from revascularisation, irrespective of the extent of the resting wall motion abnormality. [75] Furthermore transmurality of LGE is a stronger predictor of regional and global functional recovery following revascularization than resting end diastolic wall thickness. [77] The assessment of myocardial viability using a 50% transmural cut off on LGE imaging has been reported to have a sensitivity of 95% (95%CI: 93-97%) and specificity of 51% (40-62%) to predict segmental functional recovery following revascularisation. [76] Inotropic reserve assessed by low dose dobutamine has significantly higher specificity (91%) [76] suggesting a combination of the two techniques might improve diagnostic performance for those segments with 25-75% of transmural LGE. [78] Shortly after acute MI the determination of the transmural extent of infarction may be over-estimated, as some of the hyper-enhancement on LGE imaging may be due to reversible myocardial oedema, rather than non-viable scar. Despite this, the transmural extent of hyper-enhancement has been shown to predict functional recovery when performed within the first week of an acute event.
[79]
4) Non-Ischaemic Cardiomyopathies
CMR allows comprehensive evaluation of the patient with known or suspected cardiomyopathy and is recommended by the ESC guidelines for this purpose. [6] CMR is able to rule out underlying ischaemia/infarction, allows accurate estimation of biventricular volumes and function [37] and can quantify concomitant valvular heart disease. Characterisation of the extent and location of myocardial fibrosis with LGE imaging and quantification of extracellular fibrosis with T1 mapping can help diagnose and risk stratify a number of pathologies. [32] T2w pulse sequences can be used to identify myocardial oedema, and T2* pulse sequences to detect and quantify cardiac and liver iron overload in a variety of multiple transfusion syndromes (e.g.
Thalassaemia [80] ) and predict outcomes. [81] The presence of LGE has been linked to adverse outcomes in a number of the cardiomyopathies. In dilated cardiomyopathy, the finding of mid-myocardial fibrosis LGE [93] and T1 mapping [94] Pericardial constriction often presents a diagnostic challenge for the cardiologist. CMR can be used alongside cardiac CT (useful for quantification of pericardial calcification), echocardiography and invasive cardiac catheterisation to facilitate the diagnosis. In constriction the pericardium is usually, but not always, thickened; thickening may be patchy or involve the entire pericardium. Bi-atrial dilatation is ubiquitous and there may also be distortion of RV morphology. Fast cine imaging during free breathing allows real-time evaluation of ventricular interdependence (Video6). [105] Myocardial tagging techniques allow the relationship between the pericardium and the myocardium to be assessed. In a normal heart, the pericardium can be seen to slide over the myocardium during systole. In constrictive pericarditis, the pericardium is adherent to the myocardium due to the presence of fibrous adhesions and the independent relationship during systole is lost. [106] Other pericardial diseases such as tumours, cysts and congenital pericardial conditions can be characterised using CMR (Fig4).
Further reading from Bogaert and Francone. [102, 103] 
6) Vascular Imaging
CMR is well placed to perform serial vascular assessment due to its lack of ionising radiation and the relative safety of GBCA. Although CMR can be used to assess for acute aortic pathology, ease of access and fast acquisition protocols mean that CT is usually the modality of choice in this setting. The presence and direction of regurgitant jets can also be visualised during cine imaging to act as guide for optimisation of velocity sampling (Fig6a-d) . Phase-contrast CMR can be used for the assessment of stenotic lesions (Fig6e), although it shows a systematic underestimation of valvular gradients when compared with echocardiography. The technique is most useful for the quantification of valvular regurgitation, where CMR out-performs echocardiography. [116, 117] In the case of aortic and pulmonary valve regurgitation, the regurgitant fraction can be reproduced with a high degree of accuracy (Fig6e), and regurgitant fraction derived from CMR imaging has been linked with outcome in this setting. [19, 117] CMR has been demonstrated to have superiority over echocardiography for the assessment of mitral regurgitation [118] and is particularly useful post-transcatheter aortic valve implantation (TAVI)(for assessment of valvular and paravalvular aortic regurgitation). [119] Mitral regurgitation fraction can also be calculated by subtracting the aortic forward flow (derived from phase-contrast velocity mapping) from the LV stroke volume. This can be helpful in patients with suboptimal echocardiographic imaging windows or when there is a degree of uncertainty of in the severity of the mitral regurgitation, usually in the case of eccentric jets which can be underestimated by echocardiography( Figure 6 ). [120, 121] Furthermore CMR may concurrently assess the great vessels during the same examination, an important factor in cases such as bicuspid aortic valve disease (whereby coarctation and aortopathy commonly co-exist)
and Tetralogy of Fallot (whereby pulmonary arterial tree malformations are common).
8) Cardiac Mass/Tumours
Although rare, the consequences of cardiac tumours, even those of benign aetiology, can be catastrophic. CMR is excellent for differentiating cardiac thrombi from tumours [122] and plays an important role in accurately identifying some cardiac -Benign vs malignant lesions
The majority (~75%) of cardiac tumours are benign, the most common being myoxmas, lipomas, fibromas, papillary fibroelastomas and haemangiomas. [125] Benign cardiac lesions are usually well circumscribed with no evidence of local LGE image confirming hyper-enhancement confined to the fibrous lesion (star). 
